首页> 外文期刊>Analytical chemistry >Microbioassay System for Antiallergic Drug Screening Using Suspension Cells Retaining in a Poly(dimethylsiloxane) Microfluidic Device
【24h】

Microbioassay System for Antiallergic Drug Screening Using Suspension Cells Retaining in a Poly(dimethylsiloxane) Microfluidic Device

机译:使用保留在聚二甲基硅氧烷微流体装置中的悬浮细胞筛选抗过敏药物的微生物测定系统

获取原文
获取原文并翻译 | 示例
       

摘要

This article describes an antiallergic drug-screening system by the detection of histamine released from mast cells (suspension cells) on a multilayer microchip. In this study, the elastmeric mat6rial, poly(dimethylsiloxane)(PDMS), was employed to fabricate microchannels and microchambers. The microchip consists of two sections: a histamine-releasing one, which has a cell chamber, and a histamine-derivatizing one. Both were laminated to onemicrochip. Rat peritoneal mast cells were retained in the cell chamber (1.2 PL) with a filtering system using acellulose nitrate membrane. This filtering system could easily retain suspension cells without cell damage. Mastcells were viable for a sufficient time to conduct the assay on the cell chamber. The cells were stimulated with achemical release compound 48/80 (C48/80), and then histamine flowed into the lower farer, where it was derivatized to the nuorescent molecules with o-phthalal-dehyde and its fluorescence was detected on the microchip. This now system could detect the time course of the histamine release, and this microchip system required only 20 min for the assay. By this nitegrated system, 51 pmol of histamine released from 500 cells was detected, and the number of cells required for the assay was reduced to 1percent compared with conventional bulk systems. By comparing the released histamine levels with and without drugs, their effect could be evaluated. The inhibition ratio of C48/80 induced-histamine release using an antiallergic drug, disodium cromoglicate (DSCG), was related to the concentration of DSCG. This flow system was applicable for antiallergy drug screening by rapid measurement of the inhibition of histamine release from a very small amount of mast cells.
机译:本文通过检测从多层微芯片上的肥大细胞(悬浮细胞)释放的组胺来描述一种抗过敏药物筛选系统。在这项研究中,弹性材料,聚(二甲基硅氧烷)(PDMS),被用来制造微通道和微腔。该微芯片由两部分组成:一个具有组胺腔的释放组胺的部分,另一个具有组胺衍生化的部分。两者都被层压到一个微芯片上。用硝酸纤维素膜过滤系统将大鼠腹膜肥大细胞保留在细胞室(1.2 PL)中。该过滤系统可以轻松保留悬浮细胞而不会损坏细胞。肥大细胞存活足够的时间以在细胞室上进行测定。用化学释放化合物48/80(C48 / 80)刺激细胞,然后组胺流入更低的位置,在此通过邻苯二甲酸酐将其衍生为无色分子,并在微芯片上检测到荧光。现在,该系统可以检测出组胺释放的时间过程,而该微芯片系统仅需20分钟即可进行检测。通过这种集成系统,检测到从500个细胞中释放出51 pmol组胺,与传统的批量系统相比,该分析所需的细胞数减少至1%。通过比较有和没有药物时释放的组胺水平,可以评估它们的作用。使用抗过敏药物色甘酸钠(DSCG)对C48 / 80诱导的组胺释放的抑制率与DSCG的浓度有关。该流动系统可用于通过快速测量对非常少量肥大细胞释放组胺的抑制作用来进行抗过敏药物筛选。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号